Sublingual Movie Delivers Epinephrine | MedPage Lately


LOUISVILLE, Ky. — A sublingual movie could possibly ship epinephrine as successfully as intramuscular injections and supply an alternative pathway for pressing remedy of allergic anaphylaxis, a researcher instructed right here.

In checking out with wholesome volunteers, the sublingual movie loaded with AQST-109, which delivers 12 mg of epinephrine, perceived to have equivalent pharmacokinetics as 0.3 mg epinephrine delivered via injections, reported John Oppenheimer, MD, of the College of Medication and Dentistry of New Jersey/Rutgers College.

AQST-109 (12 mg) all of a sudden reached clinically significant blood concentrations, he stated in his oral presentation on the American School of Hypersensitive reaction, Bronchial asthma & Immunology (ACAAI) annual assembly.

Imply most noticed focus (Cmax) values used to be 268 pg/ml with AQST-109 (as opposed to 351 pg/ml with 0.3 mg epinephrine injection) and the time to achieve most focus in serum (Tmax) used to be 22.5 mins (as opposed to 50 mins).

The so-called EPIPHAST find out about used to be designed to be a randomized, open-label, three-part adaptive design, crossover find out about in wholesome grownup topics. 5 oral formulations have been decided via section I checking out (16 volunteers in every staff).

Those oral formulations “can ship enough blood concentrations of epinephrine faster than that noticed with the upper dose of intramuscular epinephrine injection, in step with present epinephrine autoinjectors,” stated Oppenheimer.

“The antagonistic match profiles and tolerability have been equivalent throughout all formulations and dosage strengths,” he stated. “There were no regarding protection/tolerability medical occasions associated with the magnitude of the adjustments in important indicators.”

He defined that there have been will increase in systolic blood power and middle price when the sublingual movie used to be administered, however the ones will increase have been temporary and constant to what’s observed when sufferers use epinephrine injections.

AQST-109 is being evolved as a result of intramuscular injection gadgets have “positive pitfalls,” Oppenheimer stated, together with the “loss of auto-injector availability, insufficient training of sufferers or suppliers, failure to manage in a well timed type, and the danger of unintended management.”

The oral formula “is well administered, and the protection and tolerability knowledge exhibit a good protection profile,” he famous.

“Use of a sublingual movie may just probably be a game-changer,” consultation moderator and ACAAI program chair Brian Kelly, MD, of Midwest Hypersensitive reaction and Bronchial asthma Heart in Omaha, Nebraska, informed MedPage Lately.

He famous that the analysis represented early days within the building, however that there used to be nice pastime in it. “There are numerous knowledge available in the market that take a look at parental nervousness about giving epinephrine auto-injectors the use of needles,” he stated. “To probably have a remedy that does not require a needle could be very thrilling.”

He famous {that a} nasal epinephrine software is below overview at FDA and must be to be had subsequent yr. “A sublingual movie would even be very thrilling,” he stated.

  • author['full_name']

    Ed Susman is a contract clinical creator primarily based in Castle Pierce, Florida, USA.


The find out about used to be funded by way of Aquestive Therapeutics.

Oppenheimer disclosed being on a systematic advisory board for Aquestive Therapeutics.



Please enter your comment!
Please enter your name here

Share post:


More like this

The 1998 and 2022 Vikings Are the Identical in One Regard

When making a listing of the maximum memorable...

A relating to pattern is rising amongst tax execs

A up to date survey performed through the...

15 Plus Dimension Unsightly Christmas Sweaters You Did not Know You Wanted

If there’s something that we will be able...